Ignite Creation Date:
2024-05-05 @ 9:54 PM
Last Modification Date:
2024-10-26 @ 10:10 AM
Study NCT ID:
NCT00981357
Status:
COMPLETED
Last Update Posted:
2017-09-19
First Post:
2009-09-21
Brief Title:
A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 2a Randomized Double-blinded Double Dummy Placebo And Active Controlled Two-way Cross-over Flare-enriched Multi-centre Clinical Trial To Examine The Pain Relief Produced By 2 Weeks Of Daily Oral Administration Of A Fatty Acid Amide Hydrolase Faah Inhibitor Pf-04457845 In Patients With Osteoarthritis Of The Knee
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Inactivation of the FAAH Fatty Acid Amide Hydrolase enzyme has been shown to relieve pain and inflammation in animal studies PF-04457845 has been shown to inactivate the FAAH enzyme in animals and healthy human volunteers The purpose of this study is to evaluate whether PF-04457845 can inactivate the FAAH enzyme in patients experiencing pain due to OA and whether this results in these patients experiencing less pain
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2009-014734-16 | EUDRACT_NUMBER | None | None |